{"article_title": "Life Sciences MVP: Paul Weiss' Nicholas Groombridge", "article_keywords": ["mvp", "life", "biosimilars", "groombridge", "weiss", "amgen", "wharton", "sciences", "biologics", "paul", "nicholas", "york"], "article_url": "http://www.law360.com/articles/730928/life-sciences-mvp-paul-weiss-nicholas-groombridge", "article_text": "Life Sciences MVP: Paul Weiss' Nicholas Groombridge\n\nLaw360, New York (November 25, 2015, 1:15 PM ET) -- Nicholas P. Groombridge of Paul Weiss Rifkind Wharton & Garrison LLP argued a monumental biosimilars case at the Federal Circuit and secured a historic victory for Amgen and the entire industry of brand-name biologics, placing him among Law360\u2019s Life Sciences MVPs of 2015.\n\n\n\nLIFE SCIENCES Nicholas Groombridge\n\n\n\nPaul Weiss The July triumph in Amgen Inc. v. Sandoz Inc. centered on a landmark interpretation of the Affordable Care Act\u2019s biosimilars pathway, known as the Biologics Price Competition and Innovation Act.\n\n\n\nGroombridge delivered oral arguments for Amgen at...\n\nTo view the full article, register now.", "article_metadata": {"description": "Nicholas P. Groombridge of Paul Weiss Rifkind Wharton & Garrison LLP argued a monumental biosimilars case at the Federal Circuit and secured a historic victory for Amgen and the entire industry of brand-name biologics, placing him among Law360\u2019s Life Sciences MVPs of 2015.", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/730928/life-sciences-mvp-paul-weiss-nicholas-groombridge", "csrf-token": "C0Itx/w5WsbUDHRmBuQfEGN2TCHP3A75zl6HDspKMoKbUL/7K6fVj1jmzLT+/BuBqXdJh4vLNDV9HN+xdnuj7Q==", "csrf-param": "authenticity_token", "og": {"url": "http://www.law360.com/articles/730928/life-sciences-mvp-paul-weiss-nicholas-groombridge", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "Life Sciences MVP: Paul Weiss' Nicholas Groombridge - Law360"}, "viewport": "width=device-width, initial-scale=1.0"}, "_id": "\"57477af46914bd0286fe033f\"", "article_summary": "Life Sciences MVP: Paul Weiss' Nicholas GroombridgeLaw360, New York (November 25, 2015, 1:15 PM ET) -- Nicholas P. Groombridge of Paul Weiss Rifkind Wharton & Garrison LLP argued a monumental biosimilars case at the Federal Circuit and secured a historic victory for Amgen and the entire industry of brand-name biologics, placing him among Law360\u2019s Life Sciences MVPs of 2015.\nLIFE SCIENCES Nicholas GroombridgePaul Weiss The July triumph in Amgen Inc. v. Sandoz Inc. centered on a landmark interpretation of the Affordable Care Act\u2019s biosimilars pathway, known as the Biologics Price Competition and Innovation Act.\nGroombridge delivered oral arguments for Amgen at...To view the full article, register now."}